Literature DB >> 10884372

Lysophosphatidylcholine activates p38 and p42/44 mitogen-activated protein kinases in monocytic THP-1 cells, but only p38 activation is involved in its stimulated chemotaxis.

Q Jing1, S M Xin, W B Zhang, P Wang, Y W Qin, G Pei.   

Abstract

Oxidized LDLs (OxLDLs) have been shown to be involved in recruitment of blood monocytes into the arterial subendothelial space, which is the earliest step in atherogenesis, but the underlying molecular mechanisms are poorly understood. The present study demonstrated that lysophosphatidylcholine (LPC), a major phospholipid component of OxLDL, strongly evoked phosphorylation and activation of p38 and p42/44 mitogen-activated protein kinases in monocytic cells. The stimulation of p38 and p42/44 occurred in a dose- and time-dependent manner, reaching the maximal activation at 25 microg/mL LPC within 5 minutes. Interestingly, inhibition of p38 activation by OxLDL or LPC, using its selective inhibitors (SB203580 and SKF86002), completely blocked OxLDL- or LPC-stimulated chemotaxis of THP-1 cells, which was measured in a transwell chemotaxis assay. In contrast, inhibition of p42/44 activation by its potent inhibitor (PD98059) did not block OxLDL- or LPC-stimulated chemotaxis. Moreover, expression of a p38 dominant-negative mutant (p38AF) reduced cell chemotaxis significantly. In addition, activation of p38 by LPC was apparently mediated neither by scavenger receptors nor by tyrosine kinase receptors. It was, however, effectively blocked by pertussis toxin and substantially reduced by phospholipase C inhibitor (U73122) and phosphatidylinositol 3-kinase inhibitors (wortmannin and LY294002). LPC also inhibited forskolin-stimulated cAMP accumulation in a pertussis toxin-sensitive manner, indicating that Gi/Go proteins likely mediated the effects of LPC. Our results suggested that OxLDL/LPC efficiently activated both p38 and p42/44, but only the activation of p38 was functionally associated with OxLDL-/LPC-induced chemotaxis in THP-1 cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10884372     DOI: 10.1161/01.res.87.1.52

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  16 in total

1.  Lysophosphatidylcholine suppresses apoptotic cell death by inducing cyclooxygenase-2 expression via a Raf-1 dependent mechanism in human cholangiocytes.

Authors:  G-Y Gwak; J-H Yoon; S-H Lee; S-M Lee; H-S Lee; G J Gores
Journal:  J Cancer Res Clin Oncol       Date:  2006-06-29       Impact factor: 4.553

2.  Regulation of eosinophil adhesion by lysophosphatidylcholine via a non-store-operated Ca2+ channel.

Authors:  Xiangdong Zhu; Jonathan Learoyd; Sanober Butt; Lilly Zhu; Peter V Usatyuk; Viswanathan Natarajan; Nilda M Munoz; Alan R Leff
Journal:  Am J Respir Cell Mol Biol       Date:  2007-01-11       Impact factor: 6.914

3.  Homocysteine stimulates the expression of monocyte chemoattractant protein-1 receptor (CCR2) in human monocytes: possible involvement of oxygen free radicals.

Authors:  G Wang; K O
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

4.  Silent myocardial ischemia is associated with altered plasma phospholipids.

Authors:  Hailong Lin; Jing Zhang; Peng Gao
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

Review 5.  G2A and LPC: regulatory functions in immunity.

Authors:  Janusz H Kabarowski
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-04-19       Impact factor: 3.072

6.  A plasma protein indistinguishable from ribosomal protein S19: conversion to a monocyte chemotactic factor by a factor XIIIa-catalyzed reaction on activated platelet membrane phosphatidylserine in association with blood coagulation.

Authors:  Umeko Semba; Jun Chen; Yoshihiko Ota; Nan Jia; Hidetoshi Arima; Hiroshi Nishiura; Tetsuro Yamamoto
Journal:  Am J Pathol       Date:  2010-01-21       Impact factor: 4.307

7.  Bioactive lipids, LPC and LPA, are novel prometastatic factors and their tissue levels increase in response to radio/chemotherapy.

Authors:  Gabriela Schneider; Zachariah Payne Sellers; Ahmed Abdel-Latif; Andrew J Morris; Mariusz Z Ratajczak
Journal:  Mol Cancer Res       Date:  2014-07-17       Impact factor: 5.852

8.  Lysophosphatidylcholine exhibits selective cytotoxicity, accompanied by ROS formation, in RAW 264.7 macrophages.

Authors:  Cheon Ho Park; Mee Ree Kim; Jong-Min Han; Tae-Sook Jeong; Dai-Eun Sok
Journal:  Lipids       Date:  2009-02-28       Impact factor: 1.880

9.  Lysophosphatidylcholine activates a novel PKD2-mediated signaling pathway that controls monocyte migration.

Authors:  Mingqi Tan; Feng Hao; Xuemin Xu; Guy M Chisolm; Mei-Zhen Cui
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-06-11       Impact factor: 8.311

10.  Elongated membrane tethers, individually anchored by high affinity α4β1/VCAM-1 complexes, are the quantal units of monocyte arrests.

Authors:  Calvin Chu; Emrah Celik; Felix Rico; Vincent T Moy
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.